Gross Margin

New clinical trial results for XWRAP® show a significant leap in healing diabetic ulcers, positioning Applied Biologics as a formidable player in a challenging field.

With projections of $22.7M from four new supplements, Cosmos Health is betting big on the US. But can its 'science-driven' platform deliver in a crowded market?

Rapid ticket sales for Country Stampede 2026 are just the beginning. Kustom Entertainment is leveraging market demand to fuel a major strategic expansion in Kansas.

The fast-food giant is refinancing its debt at a much higher interest rate. Is this a savvy move to optimize its balance sheet or a costly sign of trouble?

Amid widening losses and a squeezed consumer, the children's retailer is monetizing assets and cutting deep into its supply chain. A new team bets on it being enough.

As Xtract One woos investors in Vegas, its AI security tech promises safety without sacrificing freedom. But can it scale its vision of a frictionless world?

While firms spend billions on tech, a new book argues the biggest data breaches stem from leadership gaps and process failures. Is your boardroom the real front line?

FCPT's latest acquisition seems minor, but it reveals a powerful strategy for navigating economic uncertainty by targeting essential, service-based real estate.

With record profits and normalized costs, Seneca Foods is on a high. But its biggest move—reuniting the iconic Green Giant brand—is what truly reshapes its future.

AM Best's 'a-' rating on Ameriprise's new notes isn't just a grade; it's a testament to strategic foresight and a beacon for investors.

Beyond solar panels and ESG reports, JFK's $9.5B New Terminal One is a blueprint for climate-proof infrastructure. Here’s why it redefines the 2026 travel experience.

After teetering on the brink, AeroFarms' acquisition by a patient investor signals a crucial shift for the entire vertical farming sector, from VC hype to profitability.

A key deal locking in generic drug prices is extended, promising billions in savings for healthcare and providing crucial stability for a fragile industry.

Beyond telecom, IDT Corp. is leveraging its diverse portfolio in fintech, retail tech, and AI communications to drive record profits and margin expansion.

Soaring healthcare costs, fueled by GLP-1 drugs, have employers trapped. A new report shows why flexible benefits are becoming a critical survival strategy.

China's POP Culture Group reports a 141% revenue surge, fueled by digital. But as live events wane, can its IP-focused strategy win in a market of giants?

In a market drowning in price wars, one LED maker is thriving by rejecting scale for strategy. Absen's focus on value and efficiency offers a blueprint for survival.

Amidst tough sales and fierce competition, Grocery Outlet brings back its original merchandising architect and installs a new CFO to restore its bargain-hunting magic.

Inclusion in the Russell Microcap® Index is a milestone, but the real story is how the firm is engineering growth in the booming digital-first media landscape.

A tectonic shift is underway in how we get paid. Driven by AI and new laws, compensation is moving from a back-office task to a strategic business driver.